New Immunohistochemistry Test Predicts Prostate Cancer Better at its Earliest Stage
June 27, 2006 by Gloria Gamat
Filed under Diseases & Conditions
According to a study by researchers from the University of Southern California, a new prognostic test will be able to help determine if a prostate cancer patient will have a recurrence of the disease later on, even if the surrounding lymph nodes initially appear negative for cancer.
Current trials for the test developed at USC are underway to use the test in finding hidden metastases in lymph nodes and bone marrow for breast and lung cancers. Using new specific immunohistochemistry tests that can detect cancer on a cell-by-cell level, the method seems to be very powerful and better than anything else there is in predicting recurrence.
The study involving this prognostic test entitled Detection of Occult Lymph Node Metastases in Patients with Local Advanced (pT3) Node-Negative Prostate Cancer appears in the Journal of Clinical Oncology.
Read more at EurekAlert.
